Stockscreener 앱 받기
60.62
3.55%
-2.23
시간 외 거래:
60.62
Haemonetics Corp 주식(HAE)의 최신 뉴스
Citigroup Maintains Neutral Rating on Haemonetics (HAE), Lowers Price Target | HAE Stock News - GuruFocus
Citigroup Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
Haemonetics price target lowered to $70 from $75 at Citi - TipRanks
Haemonetics launches recruitment drive to expand clinical support roles - Traders Union
Assessing Haemonetics (HAE) Valuation After Recent Share Price Pullback - Yahoo Finance
A Look Back at Medical Devices & SuppliesSpecialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack - Yahoo Finance
A Review of Q4 Earnings for Medical Devices & Supplies Specialty Stocks: Comparing Haemonetics (NYSE:HAE) to Its Competitors - Bitget
Haemonetics Wins FDA Nod For Persona PLUS Plasma Growth Opportunity - simplywall.st
Haemonetics Corporation $HAE Shares Sold by Fisher Asset Management LLC - MarketBeat
Haemonetics Repays $300 Million Convertible Senior Notes Due 2026 - marketscreener.com
William Blair Investment Management LLC Buys 57,332 Shares of Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corp repays outstanding 0.00% convertible senior notesSEC filing - marketscreener.com
Haemonetics repays $300 million convertible notes at maturity By Investing.com - Investing.com Canada
Haemonetics repays $300 million convertible notes at maturity - Investing.com
Haemonetics Retires 2026 Convertible Notes, Simplifies Capital Structure - TipRanks
Haemonetics repays $300M 0.00% convertible notes due 2026 in cash - TradingView
Assessing Haemonetics (HAE) Valuation After FDA Clearance Of NexSys PCS Persona PLUS System - simplywall.st
3 Reasons HAE is Risky and 1 Stock to Buy Instead - Finviz
Haemonetics at Raymond James: Strategic Growth and Challenges - Investing.com Nigeria
Haemonetics at Raymond James: Strategic Growth and Challenges By Investing.com - Investing.com South Africa
Here's Why Haemonetics (HAE) is a Strong Value Stock - Yahoo Finance
Royce & Associates LP Sells 569,815 Shares of Haemonetics Corporation $HAE - MarketBeat
Vanguard Group Inc. Reduces Stock Position in Haemonetics Corporation $HAE - MarketBeat
Kestrel Investment Management Corp Purchases New Shares in Haemonetics Corporation $HAE - MarketBeat
Ameritas Investment Partners Inc. Has $636,000 Holdings in Haemonetics Corporation $HAE - MarketBeat
Is Haemonetics (HAE) Offering A Compelling Entry Point After Prolonged Share Price Weakness - simplywall.st
Haemonetics Corporation $HAE Stake Lessened by Citigroup Inc. - MarketBeat
Q1 EPS Estimates for Haemonetics Decreased by Zacks Research - MarketBeat
Fox Run Management L.L.C. Takes $1.36 Million Position in Haemonetics Corporation $HAE - MarketBeat
Haemonetics Completes Hemerus Medical Acquisition - Yahoo
Zacks Research Forecasts Increased Earnings for Haemonetics - MarketBeat
Therapeutic Apheresis Market to Reach US$ 6,009.58 Million - openPR.com
Haemonetics (HAE) Is Up 5.3% After FDA Clears NexSys PCS With Persona PLUS Technology - simplywall.st
Haemonetics receives FDA clearance for plasma collection system - Investing.com
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology - PR Newswire
Clark Estates Inc. NY Takes $2.24 Million Position in Haemonetics Corporation $HAE - MarketBeat
Haemonetics receives FDA clearance for plasma collection system By Investing.com - Investing.com Canada
Haemonetics Stock After Earnings: Quiet Breakout or Value Trap? - AD HOC NEWS
Isthmus Partners LLC Acquires 16,505 Shares of Haemonetics Corporation $HAE - MarketBeat
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference - PR Newswire
Haemonetics Corporation (NYSE:HAE) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Haemonetics Corporation $HAE Stock Holdings Lessened by Heartland Advisors Inc. - MarketBeat
ABN Amro Investment Solutions Buys Shares of 200,000 Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 - Finviz
Growth Recap: Will Haemonetics Corporation outperform its industry peersJuly 2025 EndofMonth & Long-Term Safe Return Strategies - baoquankhu1.vn
Assessing Haemonetics (HAE) Valuation After Recent Share Price Weakness - Yahoo Finance
A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness - simplywall.st
Strong Competitive Position Drove Haemonetics Corporation’s (HAE) Earnings Growth - Yahoo Finance
Short Interest in Haemonetics Corporation (NYSE:HAE) Decreases By 21.7% - MarketBeat
Haemonetics Corporation $HAE Shares Sold by Principal Financial Group Inc. - MarketBeat
Haemonetics Releases 2024-2025 Corporate Responsibility Report - The Globe and Mail
Haemonetics (HAE) Balances Softer Interventional Sales With Buybacks – What Story Does Guidance Tell? - simplywall.st
5 Revealing Analyst Questions From Haemonetics's Q4 Earnings Call - Finviz
2.21%
0.24%
자본화:
|
볼륨(24시간):